| Income Statement |
| Total Revenue | 43.94M |
|
| Revenues (USD) | 43.94M |
| Cost of Revenue | 24.90M |
| Gross Profit | 19.05M |
| Operating Expenses | 9.59M |
| Research and Development Expense | 1.23M |
| Selling, General and Administrative Expense | 1.59M |
| Operating Income | 9.45M |
| Income Tax Expense | 4.71M |
| Net Income | 4.74M |
| Net Income Common Stock | 4.74M |
| Net Income Common Stock (USD) | 4.74M |
| Consolidated Income | 4.74M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | 9.45M |
| Earning Before Interest & Taxes (USD) | 9.45M |
| Weighted Average Shares | 161.86M |
| Weighted Average Shares Diluted | 163.72M |
| Balance Sheet |
| Cash and Equivalents | 31.03M |
| Cash and Equivalents (USD) | 31.03M |
| Trade and Non-Trade Receivables | 15.06M |
| Current Assets | 57.49M |
| Property, Plant & Equipment Net | 138.75M |
| Total Assets | 196.42M |
| Current Liabilities | 17.25M |
| Total Liabilities | 147.61M |
| Accumulated Retained Earnings (Deficit) | -82.80M |
| Accumulated Other Comprehensive Income | -1.17M |
| Shareholders Equity | 48.81M |
| Shareholders Equity (USD) | 48.81M |
| Assets Non-Current | 138.93M |
| Inventory | 8.74M |
| Liabilities Non-Current | 130.36M |
| Trade and Non-Trade Payables | 7.29M |
| Tax Liabilities | 20.69M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 4.09M |
| Net Cash Flow from Financing | -56.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.01M |
| Capital Expenditure | -8.76M |
| Net Cash Flow from Investing | -8.76M |
| Net Cash Flow from Operations | 14.85M |
| Effect of Exchange Rate Changes on Cash | -16.00K |
| Share Based Compensation | 1.02M |